Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

about

Sitafloxacin: in bacterial infections

P2860

Q28235903-6FF9D30C-3FC0-4F4E-80D7-C20DC97ECA33

P2860

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

Item

http://www.wikidata.org/entity/Q43061626

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

@en

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

@nl

type

Item

label

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

@en

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

@nl

prefLabel

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

@en

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

@nl

P1476

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

@en

P2093

Andrew L Chan

http://www.w3.org/2001/XMLSchema#string

Timothy E Albertson

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program.

Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitis.

Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.

The pathology of chronic obstructive pulmonary disease.

Infectious etiology of acute exacerbations of chronic bronchitis.

A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

The worldwide emergence of plasmid-mediated quinolone resistance.

Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials.

When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly.

Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease

P304

539-548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERS.09.37

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477342

http://www.w3.org/2001/XMLSchema#string

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

about

P2860

P2860

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698